Mahizhaveni Balasubramanian

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

National Institute of Research in Tuberculosis(Current)

Mahizhaveni Balasubramanian is an author at National Institute of Research in Tuberculosis specializing in pharmacology, tuberculosis drug resistance, and tuberculosis pharmacotherapy.

Publications per year

2020–2023

Publications

Bacillibactin class siderophores produced by the endophyte <i>Bacillus subtilis</i> NPROOT3 as antimycobacterial agents

Yedukondalu Nalli, Sanju Singh, Apexa Gajjar et al. · Letters in Applied Microbiology · 2022 · 26 citations

Life Sciences, Microbiology, Pharmacology +17

A multi-targeting pre-clinical candidate against drug-resistant tuberculosis

Parvinder Kaur, Vijay Potluri, Vijay Kamal Ahuja et al. · Tuberculosis · 2021 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Wild-Type MIC Distribution for Re-evaluating the Critical Concentration of Anti-TB Drugs and Pharmacodynamics Among Tuberculosis Patients From South India

Azger Dusthackeer, Shainaba A. Saadhali, Manonanthini Thangam et al. · Frontiers in Microbiology · 2020 · 13 citations · Full text

Public Health, Pharmacology, Antimicrobial Pharmacotherapy +16

Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c

Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Mahizhaveni Balasubramanian et al. · International Journal of Microbiology Research · 2023 · 10 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

1–4 of 4